Literature DB >> 3104681

Phenylketonuria and scleroderma.

E H Brown, H K Berry, J Olson, J Levinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3104681     DOI： 10.1007/bf01800498

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  Intermediary metabolism of phenylalanine and tyrosine in diffuse collagen diseases. II. Influences of the low phenylalanine and tyrosine diet upon patients with collagen disease.

Authors:  N NISHIMURA; H OKAMOTO; M YASUI; K MAEDA; K OGURA
Journal:  Arch Dermatol       Date:  1959-10

2.  Pseudoscleroderma and phenylketonuria.

Authors:  G Y Guillet; N Dore; J P Hehunstre; J Maleville; J Battin
Journal:  Int J Dermatol       Date:  1983-09       Impact factor: 2.736

3.  Tryptophan metabolism in a patient with phenylketonuria and scleroderma: a proposed explanation of the indole defect in phenylketonuria.

Authors:  K N Drummond; A F Michael; R A Good
Journal:  Can Med Assoc J       Date:  1966-04-16       Impact factor: 8.262
  3 in total
  2 in total

1.  Progressive systemic scleroderma in an infant with partial phenylketonuria.

Authors:  M Haktan; A Aydin; H Bahat; B Tuysuz; H Yazici; S Altay
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Scleroderma-like skin lesions in two patients with phenylketonuria.

Authors:  T Coşkun; I Ozalp; G Kale; S Göğüş
Journal:  Eur J Pediatr       Date:  1990-12       Impact factor: 3.183
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.